Today, NOSA Nozoil is being launched in the Austrian pharmacy market together with PHOENIX AT (“PHOENIX”), one of the country’s leading pharmaceutical wholesalers.
The collaboration between NOSA and PHOENIX began in 2020 and is now expanding through the launch of Nozoil.
PHOENIX will introduce Nozoil Original and Nozoil Menthol and will actively participate in rolling out the product on the Austrian market. Through this launch, Nozoil will gain broad distribution in Austria, with availability via the country’s pharmacies, both online and in approximately 1,400 physical pharmacy locations.
PHOENIX Austria is part of the PHOENIX Group, one of Europe’s largest healthcare wholesalers and service providers, operating in 29 countries. The local organization has around 300 employees and annual revenue of approximately EUR 500 million. PHOENIX operates distribution centers in Vienna, Graz, Linz, and Hall.
“We are continuing the European rollout of Nozoil together with strong and well-established partners. PHOENIX holds a very strong position in the Austrian market, and we look forward to seeing the product on pharmacy shelves,” says Adrian Liljefors, CEO of Nosa Plugs AB.
The PHOENIX Group is one of Europe’s largest distribution companies, with annual revenue of approximately EUR 50 billion. The Group has around 48,000 employees and operates across nearly all of Europe, including Germany, Austria, France, Denmark, Italy, and Sweden. PHOENIX supplies tens of thousands of pharmacies and collaborates with nearly 18,000 pharmacies within its network, while also operating approximately 3,200 of its own pharmacies under brands such as BENU, Apotek 1, HelpNet, and Rowlands.
Nozoil is one of the world’s best-selling emollient nasal sprays for people with dry nasal mucosa — a common condition that can occur due to dry air, after a cold, or as a result of aging.